Skip to content

Efficacy of Percutaneous Auricular Vagus Nerve Stimulation in Mechanically Ventilated Patients in the ICU: A Single-Center, Double-Blind, Randomized Controlled Clinical Trial

Efficacy of Percutaneous Auricular Vagus Nerve Stimulation in Mechanically Ventilated Patients in the ICU: A Single-Center, Double-Blind, Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103411
Enrollment
Unknown
Registered
2025-05-29
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Pneumonia

Interventions

Control Group:none
Intervention Group:Percutaneous Auricular Vagus Nerve Stimulation (pAVNS)

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Establishment of artificial airway (endotracheal intubation or tracheostomy) on the day of admission. 2. Diagnosis of severe pneumonia requiring mechanical ventilation (MV) support. 3. Age between 18 and 90 years. 4. Intact skin condition at the electrode application site (no damage or infection). 5. Critical-Care Pain Observation Tool (CPOT) score = 1 (positive pain response). 6. No history of drug dependence. 7. Signed informed consent obtained from the participant and/or their legal guardian.

Exclusion criteria

Exclusion criteria: 1. Presence of an implanted pacemaker (to avoid interference from electrical stimulation). 2. Pregnancy (including suspected pregnancy). 3. Any medical history (e.g., sensory dysfunction, hemophilia, device allergy, etc.) that, in the investigator’s judgment, may interfere with the study results or increase patient risk.

Design outcomes

Primary

MeasureTime frame
Ventilator-free days within 28 days;

Secondary

MeasureTime frame
Inflammatory markers;Sedative and analgesic drug dosage;Length of stay in the ICU;28-day mortality;

Countries

China

Contacts

Public ContactHu Peng

Shanghai Tenth People's Hospital

18917683122@189.cn+86 189 1768 3122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026